U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07417904) titled 'BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis' on Feb. 02.
Brief Summary: This study evaluates the feasibility and acceptability of BRAVE, a manualized cognitive behavioral therapy (CBT)-based intervention designed to address dynamic risk factors for violence among young adults with early psychosis. Using a stepped-wedge randomized design, all participants will receive treatment as usual followed by the BRAVE intervention. The study will also explore changes in violence-related behaviors and treatment engagement over time.
Study Start Date: Feb. 16
Study Type: INTERVENTIONAL
Condition:
Violence Risk...